Comment when marking as ready: As discussed in the GMS Gastrohepatology Specialist Test Group webex call 14th Jan 2019: The Specialist Test Group agreed that there is enough evidence to rate this gene green based on unpublished data from patient cohort from USA (2,000 patients at Emory) that this is one of the Zellweger genes with significant prevalence.
Created: 28 Jan 2019, 2:10 p.m.
Initial gene list and info collated by Miranda Durkie Sheffield Diagnostic Genetics Service December 2018 on behalf of the GMS Gastrohepatology specialist test group. Gene Symbol submitted: PEX12; Suggested intial gene rating: Green; Evidence for inclusion: none given; Evidence for exclusion: none given; Technical notes (e.g. non-coding/CNV mutations requiring coverage?): none given
Created: 7 Jan 2019, 4:42 p.m.
Comment on list classification: Associated with phenotypes in OMIM and as confirmed Gen2Phen gene. At least 7 variants reported in at least 4 cases.
Created: 25 Jul 2018, 3:17 p.m.
Comment on phenotypes: Peroxisome biogenesis disorder 3A (Zellweger) 614859 includes clinical features of hepatomegaly and intrahepatic biliary dysgenesis. Genomics Clinical team consider Zellweger syndrome to be an appropriate phenotype for the Neonatal cholestasis panel.
Created: 25 Jul 2018, 2:58 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Zellwegers syndrome; cholestasis
Gene: pex12 has been classified as Green List (High Evidence).
Source Other was added to PEX12. Mode of inheritance for gene PEX12 was changed from to BIALLELIC, autosomal or pseudoautosomal Added phenotypes Peroxisome biogenesis disorder 3B 266510; Peroxisome biogenesis disorder 3A (Zellweger) 614859 for gene: PEX12 Publications for gene PEX12 were changed from to 9090384; 9354782
Source Expert Review Green was added to PEX12. Rating Changed from Red List (low evidence) to Green List (high evidence)
gene: PEX12 was added gene: PEX12 was added to Cholestasis. Sources: NHS GMS Mode of inheritance for gene: PEX12 was set to